Piccinni C - Search Results

1

Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.

Poluzzi E, Piccinni C, Carta P, Puccini A, Lanzoni M, Motola D, Vaccheri A, De Ponti F, Montanaro N. Poluzzi E, et al. Among authors: piccinni c. Eur J Clin Pharmacol. 2011 Apr;67(4):407-414. doi: 10.1007/s00228-010-0958-3. Epub 2010 Dec 9. Eur J Clin Pharmacol. 2011. PMID: 21152908

2

A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes.

Lapi F, Bianchini E, Marconi E, Medea G, Piccinni C, Maggioni AP, Dondi L, Pedrini A, Martini N, Cricelli C. Lapi F, et al. Among authors: piccinni c. Pharmacoepidemiol Drug Saf. 2023 Oct;32(10):1083-1092. doi: 10.1002/pds.5641. Epub 2023 May 29. Pharmacoepidemiol Drug Saf. 2023. PMID: 37208842

3

Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare data.

Calabria S, Ronconi G, Dondi L, Piccinni C, Pedrini A, Esposito I, Addesi A, Rossi G, Ferrara F, Venditti A, Martini N. Calabria S, et al. Among authors: piccinni c. Tumori. 2023 Oct;109(5):496-503. doi: 10.1177/03008916231153698. Epub 2023 Mar 9. Tumori. 2023. PMID: 36896466

4

[Community acquired pneumoniae and chronic obstructive pulmonary disease: the RWE analysis of events that required hospitalizations, and healthcare integrated costs.].

Ronconi G, Dondi L, Calabria S, Piccinni C, Pedrini A, Dondi L, Dell'Anno I, Esposito I, Addesi A, Viale P, Martini N. Ronconi G, et al. Among authors: piccinni c. Recenti Prog Med. 2023 Apr;118(4):204-221. doi: 10.1701/4009.39888. Recenti Prog Med. 2023. PMID: 36971159 Italian.

5

Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents.

Piccinni C, Sacripanti C, Poluzzi E, Motola D, Magro L, Moretti U, Conforti A, Montanaro N. Piccinni C, et al. Eur J Clin Pharmacol. 2010 Feb;66(2):199-206. doi: 10.1007/s00228-009-0739-z. Epub 2009 Oct 17. Eur J Clin Pharmacol. 2010. PMID: 19838692

6

Three years of experience: the Italian registry and safety data update.

Mancardi GL, Tedeschi G, Amato MP, D'Alessandro R, Drago F, Milanese C, Popoli P, Rossi P, Savettieri G, Tola MR, Comi G, Pozzilli C, Bertolotto A, Marrosu MG, Grimaldi LM, Laroni A, Vanacore N, Covezzoli A, De Rosa M, Piccinni C, Montanaro N, Periotto L, Iommelli R, Tomino C, Provinciali L. Mancardi GL, et al. Among authors: piccinni c. Neurol Sci. 2011 Jan;31 Suppl 3:295-7. doi: 10.1007/s10072-010-0356-8. Neurol Sci. 2011. PMID: 20644975

7

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting.

Piccinni C, Motola D, Marchesini G, Poluzzi E. Piccinni C, et al. Diabetes Care. 2011 Jun;34(6):1369-71. doi: 10.2337/dc10-2412. Epub 2011 Apr 22. Diabetes Care. 2011. PMID: 21515844 Free PMC article.

8

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.

Raschi E, Piccinni C, Poluzzi E, Marchesini G, De Ponti F. Raschi E, et al. Among authors: piccinni c. Acta Diabetol. 2013 Aug;50(4):569-77. doi: 10.1007/s00592-011-0340-7. Epub 2011 Oct 19. Acta Diabetol. 2013. PMID: 22008948

9

Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.

Motola D, Piccinni C, Biagi C, Raschi E, Marra A, Marchesini G, Poluzzi E. Motola D, et al. Among authors: piccinni c. Drug Saf. 2012 Apr 1;35(4):315-23. doi: 10.2165/11596510-000000000-00000. Drug Saf. 2012. PMID: 22376166

10

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group. Lapi F, et al. Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters